Blood Oxygen Level Dependent Magnetic Resonance Imaging (BOLD MRI) and Fluorothymidine Positron Emission Tomography (FLT PET) in Patients With Locally Advanced Breast Cancer Undergoing Neoadjuvant Chemotherapy

NCT01240681 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Breast Cancer (LABC)

Interventions

PROCEDURE: FLT PET and BOLD MRI scan

Sponsor

Ontario Clinical Oncology Group (OCOG)